Please try another search
For the fiscal year ended 31 December 2020, GalenikaFitofarmacija ad Zemun revenues increased 10% to RSD4.87B.Net income increased 30% to RSD890.9M. Revenues reflectSerbia (Country) segment increase of 5% to RSD3.4B, Romania(Country) segment increase of 55% to RSD102.3M. Net incomebenefited from Expense from Fair Value Adjustments decreaseof 16% to RSD490.3M (expense), Labor and Related Expensesdecrease of 6% to RSD452.6M (expense).
Period Ending: | Dec 31, 2020 | Jun 30, 2020 | Dec 31, 2019 | Jun 30, 2019 |
---|---|---|---|---|
Total Revenue | 1220.96 | 3645.23 | 1226.45 | 3196.05 |
Gross Profit | 377.11 | 1471.91 | 287.32 | 1288.09 |
Operating Income | -105.82 | 1050.11 | -149.37 | 914.54 |
Net Income | -435.46 | 1326.33 | -446.04 | 1129.41 |
Period Ending: | Dec 31, 2020 | Jun 30, 2020 | Dec 31, 2019 | Jun 30, 2019 |
---|---|---|---|---|
Total Assets | 9434.37 | 9678.58 | 8413.7 | 9111.02 |
Total Liabilities | 487.3 | 296.05 | 357.51 | 608.78 |
Total Equity | 8947.07 | 9382.53 | 8056.2 | 8502.24 |
Period Ending: | Dec 31, 2020 | Jun 30, 2020 | Dec 31, 2019 | Jun 30, 2019 |
---|---|---|---|---|
Period Length: | 12 Months | 6 Months | 12 Months | 6 Months |
Cash From Operating Activities | 749.38 | 234.25 | 653.98 | 71.63 |
Cash From Investing Activities | -801.51 | 3.35 | -369.77 | 284.71 |
Cash From Financing Activities | 0.5 | 0.04 | -193.61 | -318.32 |
Net Change in Cash | -77.58 | 240.28 | 94.61 | 39.62 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review